Article
CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 status.
PloS one - 1 Jan 2013
Zeilstra Jurrit, Joosten Sander P J, Vermeulen Louis, Koster Jan, Medema Jan Paul, Versteeg Rogier, Spaargaren Marcel, Pals Steven T
Abstract excerpt
CD44 marks stem cell-like cells in a number of tumour types, including colorectal cancer (CRC), while aberrant CD44 expression conveys increased tumourigenic, invasive, and metastatic potential. Previous data indicate that CD44 is a direct target of p53-mediated transcriptional repression in breast cancer. Since inactivating p53 mutations are frequent genetic events in CRC these could unleash expression of CD44....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
